Cargando…
α-Amidoamids as New Replacements of Antibiotics—Research on the Chosen K12, R2–R4 E. coli Strains
A preliminary study of α-amidoamids as new potential antimicrobial drugs was performed. Special emphasis was placed on selection of structure of α-amidoamids with the highest biological activity against different types of Gram-stained bacteria by lipopolysaccharide (LPS). Herein, Escherichia coli mo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697494/ https://www.ncbi.nlm.nih.gov/pubmed/33207799 http://dx.doi.org/10.3390/ma13225169 |
_version_ | 1783615612579217408 |
---|---|
author | Kowalczyk, Paweł Madej, Arleta Szymczak, Mateusz Ostaszewski, Ryszard |
author_facet | Kowalczyk, Paweł Madej, Arleta Szymczak, Mateusz Ostaszewski, Ryszard |
author_sort | Kowalczyk, Paweł |
collection | PubMed |
description | A preliminary study of α-amidoamids as new potential antimicrobial drugs was performed. Special emphasis was placed on selection of structure of α-amidoamids with the highest biological activity against different types of Gram-stained bacteria by lipopolysaccharide (LPS). Herein, Escherichia coli model strains K12 (without LPS in its structure) and R1–R4 (with different length LPS in its structure) were used. The presented work showed that the antibacterial activity of α-amidoamids depends on their structure and affects the LPS of bacteria. Moreover, the influence of various newly synthesized α-amidoamids on bacteria possessing smooth and rought LPS and oxidative damage of plasmid DNA caused by all newly obtained compounds was indicated. The presented studies clearly explain that α-amidoamids can be used as substitutes for antibiotics. The chemical and biological activity of the analysed α-amidoamids was associated with short alkyl chain and different isocyanides molecules in their structure such as: tetr-butyl isocyanide or 2,5-dimethoxybenzyl isocyanide. The observed results are especially important in the case of the increasing resistance of bacteria to various drugs and antibiotics. |
format | Online Article Text |
id | pubmed-7697494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76974942020-11-29 α-Amidoamids as New Replacements of Antibiotics—Research on the Chosen K12, R2–R4 E. coli Strains Kowalczyk, Paweł Madej, Arleta Szymczak, Mateusz Ostaszewski, Ryszard Materials (Basel) Article A preliminary study of α-amidoamids as new potential antimicrobial drugs was performed. Special emphasis was placed on selection of structure of α-amidoamids with the highest biological activity against different types of Gram-stained bacteria by lipopolysaccharide (LPS). Herein, Escherichia coli model strains K12 (without LPS in its structure) and R1–R4 (with different length LPS in its structure) were used. The presented work showed that the antibacterial activity of α-amidoamids depends on their structure and affects the LPS of bacteria. Moreover, the influence of various newly synthesized α-amidoamids on bacteria possessing smooth and rought LPS and oxidative damage of plasmid DNA caused by all newly obtained compounds was indicated. The presented studies clearly explain that α-amidoamids can be used as substitutes for antibiotics. The chemical and biological activity of the analysed α-amidoamids was associated with short alkyl chain and different isocyanides molecules in their structure such as: tetr-butyl isocyanide or 2,5-dimethoxybenzyl isocyanide. The observed results are especially important in the case of the increasing resistance of bacteria to various drugs and antibiotics. MDPI 2020-11-16 /pmc/articles/PMC7697494/ /pubmed/33207799 http://dx.doi.org/10.3390/ma13225169 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kowalczyk, Paweł Madej, Arleta Szymczak, Mateusz Ostaszewski, Ryszard α-Amidoamids as New Replacements of Antibiotics—Research on the Chosen K12, R2–R4 E. coli Strains |
title | α-Amidoamids as New Replacements of Antibiotics—Research on the Chosen K12, R2–R4 E. coli Strains |
title_full | α-Amidoamids as New Replacements of Antibiotics—Research on the Chosen K12, R2–R4 E. coli Strains |
title_fullStr | α-Amidoamids as New Replacements of Antibiotics—Research on the Chosen K12, R2–R4 E. coli Strains |
title_full_unstemmed | α-Amidoamids as New Replacements of Antibiotics—Research on the Chosen K12, R2–R4 E. coli Strains |
title_short | α-Amidoamids as New Replacements of Antibiotics—Research on the Chosen K12, R2–R4 E. coli Strains |
title_sort | α-amidoamids as new replacements of antibiotics—research on the chosen k12, r2–r4 e. coli strains |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697494/ https://www.ncbi.nlm.nih.gov/pubmed/33207799 http://dx.doi.org/10.3390/ma13225169 |
work_keys_str_mv | AT kowalczykpaweł aamidoamidsasnewreplacementsofantibioticsresearchonthechosenk12r2r4ecolistrains AT madejarleta aamidoamidsasnewreplacementsofantibioticsresearchonthechosenk12r2r4ecolistrains AT szymczakmateusz aamidoamidsasnewreplacementsofantibioticsresearchonthechosenk12r2r4ecolistrains AT ostaszewskiryszard aamidoamidsasnewreplacementsofantibioticsresearchonthechosenk12r2r4ecolistrains |